The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for postmenopausal women, which makes this the first medication for low sexual ...

The U.S. Food and Drug Administration recently expanded approval of Addyi, a daily pill for low sex drive, to postmenopausal ...

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

The once-a-day treatment, which acts on brain chemicals that affect mood and appetite, had initially been OK’d for ...

FDA approves drug for women's sexual health concerns, a new study examines nail fungus impact on athletic performance while supplement labeling rules reviewed.

In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...

Addyi, the first FDA-approved medication for low libido in women under 65, offers a new treatment option. Learn about its ...

Addyi, the first and only FDA-approved pill clinically proven to treat frustrating low sexual desire in women, is now approved for use in women who have gone through menopause RALEIGH, N.C., Dec. 15, ...